141 related articles for article (PubMed ID: 38114011)
1. Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2.
Waqas M; Ullah S; Halim SA; Rehman NU; Ali A; Jan A; Muhsinah AB; Khan A; Al-Harrasi A
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128812. PubMed ID: 38114011
[TBL] [Abstract][Full Text] [Related]
2. Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches.
Bhowmick S; Saha A; AlFaris NA; ALTamimi JZ; ALOthman ZA; Aldayel TS; Wabaidur SM; Islam MA
J Mol Graph Model; 2022 Mar; 111():108113. PubMed ID: 34959151
[TBL] [Abstract][Full Text] [Related]
3. A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2.
Singh E; Jha RK; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK
Comput Biol Chem; 2022 Aug; 99():107721. PubMed ID: 35835027
[TBL] [Abstract][Full Text] [Related]
4. Combining computational and experimental evidence on the activity of antimalarial drugs on papain-like protease of SARS-CoV-2: A repurposing study.
Ribaudo G; Yun X; Ongaro A; Oselladore E; Ng JPL; Haynes RK; Law BYK; Memo M; Wong VKW; Coghi P; Gianoncelli A
Chem Biol Drug Des; 2023 Apr; 101(4):809-818. PubMed ID: 36453012
[TBL] [Abstract][Full Text] [Related]
5. Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study.
Rahul S; Sarkar A
J Biomol Struct Dyn; 2022; 40(24):13848-13858. PubMed ID: 34730069
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro.
Arya R; Prashar V; Kumar M
Int J Biol Macromol; 2023 Mar; 230():123347. PubMed ID: 36682650
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease.
Srinivasan V; Brognaro H; Prabhu PR; de Souza EE; Günther S; Reinke PYA; Lane TJ; Ginn H; Han H; Ewert W; Sprenger J; Koua FHM; Falke S; Werner N; Andaleeb H; Ullah N; Franca BA; Wang M; Barra ALC; Perbandt M; Schwinzer M; Schmidt C; Brings L; Lorenzen K; Schubert R; Machado RRG; Candido ED; Oliveira DBL; Durigon EL; Niebling S; Garcia AS; Yefanov O; Lieske J; Gelisio L; Domaracky M; Middendorf P; Groessler M; Trost F; Galchenkova M; Mashhour AR; Saouane S; Hakanpää J; Wolf M; Alai MG; Turk D; Pearson AR; Chapman HN; Hinrichs W; Wrenger C; Meents A; Betzel C
Commun Biol; 2022 Aug; 5(1):805. PubMed ID: 35953531
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19.
Hersi F; Sebastian A; Tarazi H; Srinivasulu V; Mostafa A; Allayeh AK; Zeng C; Hachim IY; Liu SL; Abu-Yousef IA; Majdalawieh AF; Zaher DM; Omar HA; Al-Tel TH
Eur J Med Chem; 2023 Jun; 254():115380. PubMed ID: 37075625
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro.
Große M; Setz C; Rauch P; Auth J; Morokutti-Kurz M; Temchura V; Schubert U
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891385
[TBL] [Abstract][Full Text] [Related]
10. Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease.
Zou Z; Shan H; Sun D; Xia L; Shi Y; Wan J; Zhou A; Wu Y; Xu H; Lei H; Xu Z; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1133-1139. PubMed ID: 35866602
[TBL] [Abstract][Full Text] [Related]
11. Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA.
Kumari R; Kumar V; Dhankhar P; Dalal V
J Biomol Struct Dyn; 2023 Jul; 41(10):4650-4666. PubMed ID: 35510600
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site.
van Vliet VJE; Huynh N; Palà J; Patel A; Singer A; Slater C; Chung J; van Huizen M; Teyra J; Miersch S; Luu GK; Ye W; Sharma N; Ganaie SS; Russell R; Chen C; Maynard M; Amarasinghe GK; Mark BL; Kikkert M; Sidhu SS
PLoS Pathog; 2022 Dec; 18(12):e1011065. PubMed ID: 36548304
[TBL] [Abstract][Full Text] [Related]
13. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
Lindner HA; Fotouhi-Ardakani N; Lytvyn V; Lachance P; Sulea T; Ménard R
J Virol; 2005 Dec; 79(24):15199-208. PubMed ID: 16306591
[TBL] [Abstract][Full Text] [Related]
14. Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors.
Valipour M
Eur J Med Chem; 2022 Oct; 240():114572. PubMed ID: 35797899
[TBL] [Abstract][Full Text] [Related]
15. Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease.
Liu W; Wang J; Wang S; Yue K; Hu Y; Liu X; Wang L; Wan S; Xu X
Bioorg Chem; 2023 Nov; 140():106830. PubMed ID: 37683544
[TBL] [Abstract][Full Text] [Related]
16. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.
Patchett S; Lv Z; Rut W; Békés M; Drag M; Olsen SK; Huang TT
Cell Rep; 2021 Sep; 36(13):109754. PubMed ID: 34547223
[TBL] [Abstract][Full Text] [Related]
17. Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations.
Holmes J; Islam SM; Milligan KA
Viruses; 2024 May; 16(6):. PubMed ID: 38932170
[TBL] [Abstract][Full Text] [Related]
18. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease.
Nayak D; Dos Santos Bury P; Drag M; Nijkerk AN; El Oualid F; Olsen SK
Methods Mol Biol; 2023; 2591():171-188. PubMed ID: 36350549
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of metal ions for COVID-19: insights from the papain-like protease of SARS-CoV-2.
Shetler CL; Ferreira JC; Cardoso THS; Silva EMA; Saksena NK; Rabeh WM
Biochem J; 2022 Oct; 479(20):2175-2193. PubMed ID: 36205308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
